Marked response of burning mouth syndrome to pregabalin treatment

Clinical and Experimental Dermatology

Volumn 34, Issue 7, 2009, Pages

  Lopez V ^a   Alonso, V ^a   Marti N ^a   Calduch, L ^a   Jorda E ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; GLUCOSE; IRON; PREGABALIN; VITAMIN B GROUP; ZINC;

ADULT; ANAMNESIS; BLOOD CELL COUNT; BURNING MOUTH SYNDROME; CARPAL TUNNEL SYNDROME; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LABORATORY TEST; LETTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANALGESICS, NON-NARCOTIC; BURNING MOUTH SYNDROME; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MIDDLE AGED;

EID: 70349496423     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03493.x     Document Type: Letter

References (5)

1. Brufau-Redondo C, Martín-Brufau R, Corbalán-Velez R et al. Burning mouth syndrome. Actas Dermosifiliogr 2008 99 : 431 440.
2. Jääskeläinen SK, Forssel H, Tenovuo O. Abnormalities of the reflex in burning mouth syndrome. Pain 1997 73 : 455 460.
3. Dubey PK. Gabapentin for the treatment of glossodynia due to an unusual case. Anesth Analg 2008 107 : 729.
4. Femiano F, Gombos F, Scully C. Burning mouth syndrome (BMS): open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004 9 : 8 13.
5. Argoff CE, Backonja MM, Belgrade MJ et al. Consensus guidelines: treatment planning and options. Mayo Clin Proc 2006 81 (Suppl. 4 S12 25.